Stay updated with breaking news from Robert Ajer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP Jeffrey Robert Ajer sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $90.00, for a total value of $450,000.00. Following the completion of the sale, the executive vice president now […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP Jeffrey Robert Ajer sold 5,000 shares of the firm’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $90.00, for a total value of $450,000.00. Following the sale, the executive vice president now directly owns 60,804 shares of […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) is set to issue its quarterly earnings data after the market closes on Wednesday, April 26th. Analysts expect the company to announce earnings of $0.43 per share for the quarter. BioMarin Pharmaceutical has set its FY 2023 guidance at $1.80-$2.05 EPS.Individual that wish to register for the company’s earnings […]
Emerald Advisers LLC bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 8,845 shares of the biotechnology company’s stock, valued at approximately $915,000. Other hedge funds and other institutional investors have also recently bought […]
DekaBank Deutsche Girozentrale boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 2.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 296,567 shares of the biotechnology company’s stock after buying an additional 7,280 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in BioMarin Pharmaceutical were worth $30,273,000 as of its […]